Boenning & Scattergood’s Agilent Technologies A Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$1.12M Hold
8,496
0.18% 141
2022
Q3
$1.03M Hold
8,496
0.21% 123
2022
Q2
$1.01M Hold
8,496
0.19% 128
2022
Q1
$1.12M Buy
8,496
+59
+0.7% +$8.12K 0.18% 141
2021
Q4
$1.35M Buy
8,437
+301
+4% +$46.9K 0.22% 119
2021
Q3
$1.28M Sell
8,136
-1
-0% -$162 0.23% 112
2021
Q2
$1.2M Hold
8,137
0.21% 122
2021
Q1
$1.03M Buy
8,137
+880
+12% +$109K 0.2% 131
2020
Q4
$860K Hold
7,257
0.18% 139
2020
Q3
$732K Hold
7,257
0.18% 144
2020
Q2
$641K Hold
7,257
0.17% 144
2020
Q1
$520K Buy
7,257
+60
+0.8% +$4.82K 0.18% 135
2019
Q4
$614K Buy
7,197
+800
+13% +$63K 0.16% 159
2019
Q3
$490K Sell
6,397
-238
-4% -$17.2K 0.14% 170
2019
Q2
$495K Sell
6,635
-49
-0.7% -$3.63K 0.14% 167
2019
Q1
$537K Hold
6,684
0.16% 154
2018
Q4
$451K Buy
6,684
+1
+0% +$67 0.16% 161
2018
Q3
$471K Buy
6,683
+75
+1% +$4.96K 0.15% 173
2018
Q2
$409K Buy
+6,608
New +$431K 0.13% 185

Other funds holding A

Boenning & Scattergood's A Position: Q4 2022 in Review

Boenning & Scattergood held its Agilent Technologies (A) position steady in Q4 2022 at 8,496 shares worth $1.12M. The position accounts for 0.18% of the portfolio, ranked #141.

Boenning & Scattergood first reported a position in A in Q2 2018 and has held it in 19 quarters since. The position peaked at $1.35M in Q4 2021. 964 funds tracked by Wall St. Rank hold A as of Q4 2022.

  • Boenning & Scattergood held 8,496 shares of Agilent Technologies worth $1.12M as of Q4 2022.
  • Boenning & Scattergood left its Agilent Technologies share count unchanged in Q4 2022.
  • Agilent Technologies made up 0.18% of Boenning & Scattergood's portfolio in Q4 2022, its #141 holding.
  • Boenning & Scattergood first reported a position in Agilent Technologies in Q2 2018 and has held it in 19 quarters since.
  • Boenning & Scattergood's Agilent Technologies position peaked at $1.35M in Q4 2021.
  • 964 funds tracked by Wall St. Rank held Agilent Technologies as of Q4 2022.

Based on Boenning & Scattergood's 13F filing for Q4 2022, filed 26 Jan 2023.